Francisca Guijarro

17PUBLICATIONS
78CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical microbiology not elsewhere classifiedMedical biotechnology not elsewhere classifiedMedical infection agents (incl. prions)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 06, 2025
A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias.

Lorena Pérez-Amill, Mercedes Armand-Ugón, Maria Val-Casals

|Jan 11, 2025
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

Guadalupe Oñate, Ana Garrido, Montserrat Arnan

|Jan 08, 2025
At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens.

Alexandra Martínez-Roca, Carlos Jiménez-Vicente, Beatriz Merchán

|Oct 10, 2024
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular.

Sandra Castaño-Díez, Mònica López-Guerra, Inés Zugasti

|Aug 29, 2024
Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.

Francesca Guijarro, Sandra Castaño-Díez, Carlos Jiménez-Vicente

|Feb 24, 2024
Infrequent Presentations of Chronic NPM1-Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature.

Sandra Castaño-Díez, Francesca Guijarro, Mònica López-Guerra

Pageof 3

Frequent Collaborators

8 joint publications

Sandra Castaño-Díez

7 joint publications

Jordi Esteve

6 joint publications

Alex Bataller

6 joint publications

Dolors Colomer